Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic
- PMID: 32406119
- PMCID: PMC7272894
- DOI: 10.1111/apt.15759
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic
Abstract
LINKED CONTENT
This article is linked to King et al papers. To view these articles, visit
Comment in
-
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14. Aliment Pharmacol Ther. 2020. PMID: 32406090 Free PMC article.
Comment on
-
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1. Aliment Pharmacol Ther. 2020. PMID: 32237083
References
-
- King D, Reulen RC, Thomas T, et al. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000–2018. Aliment Pharmacol Ther. 2020;51:922‐934. - PubMed
-
- Piovani D, Danese S, Peyrin‐Biroulet L, Nikolopoulos GK, Bonovas S. Systematic review with meta‐analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020;51:820‐830. - PubMed
-
- Malham M, Jakobsen C, Paerregaard A, Virta LJ, Kolho K‐L, Wewer V. The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23‐year period: a population‐based study. Aliment Pharmacol Ther. 2019;50:33‐39. - PubMed
-
- Chu TPC, Grainge MJ, Card TR. The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity. Aliment Pharmacol Ther. 2018;48:1099‐1108. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources